Atrial Fibrillation Prevalence Rates and Its Association with Cardiovascular–Kidney–Metabolic Factors: SIMETAP-AF Study
Open Access
Abstract
Background and Objectives: Atrial fibrillation (AF) is the most frequent arrhythmia and the main cause of hospital admissions for cardioembolic stroke. The SIMETAP research project aims to update the prevalence rates of cardiovascular, renal, or metabolic factors and to evaluate their respective associations with factors that could be related. The present study aims to assess the AF prevalence rates in an adult population and its association with cardiovascular–kidney–metabolic (CKM) factors. Materials and Methods: This cross-sectional observational study was conducted in a primary care setting, with a population-based random sample of 6588 people aged 18.0–102.8 years. Crude and adjusted prevalence rates of AF were calculated. The associations of CKM factors with AF were assessed using bivariate and multivariate analysis. Results: The age- and sex-adjusted prevalence rates of AF were 2.9% in the overall adult population, 6.1% in the population aged ≥50 years, and 12.9% in the population aged ≥70 years, with no significant differences by sex. AF prevalence in the population under 50 years of age barely reached 1‰. Heart failure (HF), hypertension, chronic kidney disease (CKD), stroke, low HDL-cholesterol, and prediabetes were independent CKM factors associated with AF in the overall population, as were the same factors, except prediabetes, in the population ≥50 years old (p < 0.001). High or very high vascular risk was present in 92.4% [95% CI: 89.1–95.7]) of the population with AF. Conclusions: The adjusted prevalence rate of AF in the population aged 50 years or older was 6.1%, twice that of the overall adult population and half that of the population aged 70 years or older. The main independent CKM factors associated with AF were HF, stroke, CKD, hypertension, and low HDL-cholesterol.Keywords
Funding Information
- SIMETAP study (05/2010RS)
This publication has 54 references indexed in Scilit:
- Prevalence rates of chronic kidney disease and its association with cardiometabolic factors and cardiovascular diseases. SIMETAP-CKD studyClínica e Investigación en Arteriosclerosis (English Edition), 2023
- Blood pressure, hypertension and the risk of atrial fibrillation: a systematic review and meta-analysis of cohort studiesEuropean Journal of Epidemiology, 2023
- Chronic Kidney Disease and Risk of Atrial Fibrillation and Heart Failure in General Population-Based Cohorts: The BiomarCaRE ProjectESC Heart Failure, 2021
- Incidence and Predictors of Heart Failure in Patients With Atrial FibrillationCJC Open, 2021
- Population and methodology of the SIMETAP study: Prevalence of cardiovascular risk factors, cardiovascular diseases, and related metabolic diseasesClínica e Investigación en Arteriosclerosis (English Edition), 2018
- Silent atrial fibrillation: epidemiology, diagnosis, and clinical impactClinical Cardiology, 2017
- 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial FibrillationJACC, 2014
- 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemiaArthritis Care & Research, 2012
- Smoking and incidence of atrial fibrillation: Results from the Atherosclerosis Risk in Communities (ARIC) StudyHeart Rhythm, 2011
- Independent Risk Factors for Atrial Fibrillation in a Population-Based CohortJAMA, 1994